Proniosomes as a Drug Carrier for Transdermal Delivery of Candesartan Cilexetil

Journal Title: International Journal of Nano Studies & Technology (IJNST) - Year 2013, Vol 2, Issue 2

Abstract

Candesartan Cilexetil is an angiotensin II receptor antagonist widely used in the treatment of hypertension and characterized by its good efficacy and less side effects compared to other angiotensin II receptor antagonist. The aim of the study was to develop a proniosomal carrier system for Candesartan Cilexetil for the treatment of hypertension that is capable of efficiently delivering entrapped drug over an extended period of time. In the present study transdermal Candesartan Cilexetil proniosomal gels was formulated by using Lecithin, Cholesterol as encapsulating agents, Surfactant, Span and permeation enhancers by coacervation phase separation method. The prepared systems were characterized for pH determination, Viscosity, Vesicle size analysis, rate of spontaneity, encapsulation efficiency, in vitro release study and ex- vivo skin permeation study, skin irritation study and stability study. It was observed that the gel formulations showed good spreadability and viscosity. The particle size was found to be in the range of 175.0- 277.7 nm. The proniosomes showed spherical and homogenous structure in optical microscopy. All formulations showed zero order drug release by diffusion mechanism. The stability studies showed that proniosomal gels were stable at 4 to 8o C and 25±2o C. The above results indicated that the proniosomal gel could be formulated for controlled release of Candesartan Cilexetil. The proniosomal gel are suitable for Candesartan Cilexetil once a day controlled release formulation. The investigated Candesartan cilexetil loaded proniosomal formula proved to be non-irritant, with significantly higher antihypertensive effects and reasonably good stability characteristics

Authors and Affiliations

Sanjar Alam

Keywords

Related Articles

Nanoparticle Based Combination Treatments for Targeting Multiple Hallmarks of Cancer

Treatment of cancer remains one of the most challenging tasks facing the healthcare system. Cancer affects the lives of millions of people and is often fatal. Current treatment methods include surgery, chemotherapy, radi...

Tissue Depth Study for a Fully Implantable, Remotely Powered and Programmable Wireless Neural Stimulator

Miniature, remotely powered and programmable neural stimulators were implanted on the sciatic nerve in nine pig hind limbs. An external dipole antenna was used to transmit power and waveforms to the implant at 915 MHz. F...

Efficiency Enhancement of Solar Cell Using Metamaterials

In this work, Photovoltaic (PV) cell model with high absorption efficiency is introduced. The proposed four layer PV cell model consists of antireflection coating (ARC) layer on glass based and covered by metamaterial (M...

Renoprotective and antioxidant renal effects of cilnidipine in DOCA Salt -Treated Albino Rats

Aim: Cilnidipine is a dihydropyridine calcium channel blocker (CCB) that blocks both L-type and N- type channels at the smooth muscle in the artery and calcium channels at the presynaptic nerve terminal, respectively. It...

The Time of Engineers In Graphene Research

The Time of Engineers In Graphene Research

Download PDF file
  • EP ID EP201457
  • DOI 10.19070/2167-8685-130004
  • Views 82
  • Downloads 0

How To Cite

Sanjar Alam (2013). Proniosomes as a Drug Carrier for Transdermal Delivery of Candesartan Cilexetil. International Journal of Nano Studies & Technology (IJNST), 2(2), 17-22. https://europub.co.uk/articles/-A-201457